126 related articles for article (PubMed ID: 25439236)
1. Cardiac morbidity in an HIV-1 lipodystrophy patient cohort expressing the TNF-α-238 G/A single nucleotide gene polymorphism.
Mahajan SD; Gaekwad A; Pawar J; Tripathy S; Ghate M; Bhattacharya J; Singh HO; Schwartz SA; Paranjape R; Gangakhedkar R
Curr HIV Res; 2015; 13(2):98-108. PubMed ID: 25439236
[TBL] [Abstract][Full Text] [Related]
2. No relationship between TNF-α genetic variants and combination antiretroviral therapy-related lipodystrophy syndrome in HIV type 1-infected patients: a case-control study and a meta-analysis.
Veloso S; Olona M; Peraire J; Viladés C; Pardo P; Domingo P; Asensi V; Broch M; Aguilar C; López-Dupla M; Aragonés G; Garcia-Pardo G; Sirvent JJ; Vendrell J; Richart C; Vidal F;
AIDS Res Hum Retroviruses; 2011 Feb; 27(2):143-52. PubMed ID: 20854131
[TBL] [Abstract][Full Text] [Related]
3. TNF microsatellite alleles may confer protection against the development of lipodystrophy syndrome in Brazilian HIV patients.
Silva MM; Simões RT; Castelli EC; Mendes-Junior CT; Deghaide NH; Tsuda LC; Machado AA; Donadi EA; Fernandes AP
Int J Immunogenet; 2010 Oct; 37(5):379-85. PubMed ID: 20518840
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy.
Maher B; Alfirevic A; Vilar FJ; Wilkins EG; Park BK; Pirmohamed M
AIDS; 2002 Oct; 16(15):2013-8. PubMed ID: 12370499
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of the expression of TNF-alpha, TGF-beta, and caspase-3 in subcutaneous tissue of patients with HIV lipodystrophy syndrome.
de Souza Dantas Oliveira SH; de Souza Aarão TL; da Silva Barbosa L; Souza Lisbôa PG; Tavares Dutra CD; Margalho Sousa L; Simões Quaresma JA; Feio Libonati RM
Microb Pathog; 2014; 67-68():41-7. PubMed ID: 24583153
[TBL] [Abstract][Full Text] [Related]
6. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
Tarr PE; Taffé P; Bleiber G; Furrer H; Rotger M; Martinez R; Hirschel B; Battegay M; Weber R; Vernazza P; Bernasconi E; Darioli R; Rickenbach M; Ledergerber B; Telenti A;
J Infect Dis; 2005 May; 191(9):1419-26. PubMed ID: 15809899
[TBL] [Abstract][Full Text] [Related]
7. The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy.
Marzocchetti A; Schwarz J; Di Giambenedetto S; Colafigli M; Bracciale L; Fabbiani M; Fantoni M; Trecarichi E; Cauda R; De Luca A
AIDS Res Hum Retroviruses; 2011 Dec; 27(12):1299-309. PubMed ID: 21595566
[TBL] [Abstract][Full Text] [Related]
8. Lipodystrophy and insulin resistance in combination antiretroviral treated HIV-1-infected patients: implication of resistin.
Escoté X; Miranda M; Veloso S; Domingo P; Alonso-Villaverde C; Peraire J; Viladés C; Alba V; Olona M; Castro A; López-Dupla M; Sirvent JJ; Vicente V; Vendrell J; Richart C; Vidal F;
J Acquir Immune Defic Syndr; 2011 May; 57(1):16-23. PubMed ID: 21317795
[TBL] [Abstract][Full Text] [Related]
9. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.
Barbaro G
Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554
[TBL] [Abstract][Full Text] [Related]
10. SNPs in the APM1 gene promoter are associated with adiponectin levels in HIV-infected individuals receiving HAART.
Trinca JR; Sprinz E; Lazzaretti RK; Hutz MH; Kuhmmer R; de Almeida S; Tibola A; Meirelles GB; Arena-de-Souza RC; Mattevi VS
J Acquir Immune Defic Syndr; 2010 Nov; 55(3):299-305. PubMed ID: 20964254
[TBL] [Abstract][Full Text] [Related]
11. Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome.
Ledru E; Christeff N; Patey O; de Truchis P; Melchior JC; Gougeon ML
Blood; 2000 May; 95(10):3191-8. PubMed ID: 10807787
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in estrogen receptors and sexual dimorphism in fat redistribution in HIV-infected patients on HAART.
Gasparotto AS; Sprinz E; Lazzaretti RK; Kuhmmer R; Silveira JM; Basso RP; Pinheiro CA; Silveira MF; Ribeiro JP; Mattevi VS
AIDS; 2012 Jan; 26(1):19-26. PubMed ID: 22011627
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy.
Nolan D; Moore C; Castley A; Sayer D; Mamotte C; John M; James I; Mallal S
AIDS; 2003 Jan; 17(1):121-3. PubMed ID: 12478078
[No Abstract] [Full Text] [Related]
14. Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.
Tarr PE; Telenti A
Antivir Ther; 2007; 12(7):999-1013. PubMed ID: 18018758
[TBL] [Abstract][Full Text] [Related]
15. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
[TBL] [Abstract][Full Text] [Related]
16. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
[TBL] [Abstract][Full Text] [Related]
17. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients.
Jan V; Cervera P; Maachi M; Baudrimont M; Kim M; Vidal H; Girard PM; Levan P; Rozenbaum W; Lombès A; Capeau J; Bastard JP
Antivir Ther; 2004 Aug; 9(4):555-64. PubMed ID: 15456087
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.
Lihn AS; Richelsen B; Pedersen SB; Haugaard SB; Rathje GS; Madsbad S; Andersen O
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1072-80. PubMed ID: 12876073
[TBL] [Abstract][Full Text] [Related]
19. Lipodystrophy in patients with HIV-1 infection: effect of stopping protease inhibitors on TNF-alpha and TNF-receptor levels, and on metabolic parameters.
Maher B; Lloyd J; Wilkins EG; Fraser WD; Back D; Park BK; Pirmohamed M
Antivir Ther; 2004 Dec; 9(6):879-87. PubMed ID: 15651746
[TBL] [Abstract][Full Text] [Related]
20. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance.
Bastard JP; Caron M; Vidal H; Jan V; Auclair M; Vigouroux C; Luboinski J; Laville M; Maachi M; Girard PM; Rozenbaum W; Levan P; Capeau J
Lancet; 2002 Mar; 359(9311):1026-31. PubMed ID: 11937183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
